AI Analysis

How does KREBSBIO.NS make money? Does KREBSBIO.NS have pricing power? What's the Earnings Whisper? Will KREBSBIO.NS profit more as the business scales? What is KREBSBIO.NS's management track record? Is KREBSBIO.NS's current price justified?

Krebs Biochemicals & Industries Limited

₹60.19 -$9.73 (-13.92%)

NSE · 16 Oct 2026 09:56 UTC

Previous Close

₹60.82

Day Range

₹58.21₹60.99

Year Range

₹38.33₹76.85

Market Cap

1.3B

AVG Volume

20.3K

Trailing/Forward PE

-9.2/-

PEG ratio

-0.13

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

KREBSBIO.NS Revenue (INR) by year
Period	Revenue (INR)
2026	237.32M
2025	433.12M
2024	504.21M
2023	521.34M
2022	569.9M
2021	413.91M
2020	271.02M
2019	393.11M
2018	333.89M
2017	31.4M

Net Income (INR) · A

KREBSBIO.NS Net Income (INR) by year
Period	Net Income (INR)
2026	-169.33M
2025	-269.39M
2024	-197.28M
2023	-246.92M
2022	-445.27M
2021	-283.59M
2020	-288.72M
2019	-200.12M
2018	-178.25M
2017	-160.5M

Operating Income (INR) · A

KREBSBIO.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	-118.73M
2025	-217.19M
2024	-154.9M
2023	-218.71M
2022	-402.43M
2021	-225.74M
2020	-227.54M
2019	-148.66M
2018	-114.57M
2017	-140.17M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Krebs Biochemicals & Industries Limited

Video analysis: KREBSBIO.NS

News: KREBSBIO.NS

Similar companies